shape therapeutics leadership team
So far, I like the team. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . focus on diversity and equityRead More. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Chief Scientific Officer, Francois Vigneault Do you excel more in a team or individual setting? Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. We know why we get up every day and work as hard as we do. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Highlight your management teams expertise. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Legal Name Shape Therapeutics, Inc. Company Type For Profit. Learn more. . Shape Therapeutics's key executives include David Huss and 11 others. All rights reserved. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Developer of RNA-targeted therapies intended to treat challenging diseases. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, By continuing to use this site you are consenting to these choices. Shape Life! In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. We have plenty of data and we can help. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. free lookups / month. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Lorem ipsum dolor sit, amet consectetur adipisicing elit. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Shape Therapeutics's Vice President, Head of Research is David Huss. . Shape Life! The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. This is a profile preview from the PitchBook Platform. No credit card required. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. The company closed a series B financing led by . The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. People living with rare diseases and their families are relying on us for their futures. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. It focuses on RNA-editing gene therapy. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Shape Therapeutics, Inc. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Headquarters Location 219 Terry Ave N Suite 100 Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Seattle, WA 98109, 75 Kneeland Street Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Our Commitment to Diversity. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. We have to be creative; we need to transform the paradigm. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Shape Therapeutics, Inc. Chief Operating Officer. Shape Life! Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . ", I feel this real connection to the patients were having an impact on. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. Shape Therapeutics, Inc. employs 14 employees. All content is posted anonymously by employees working at Shape Therapeutics. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Operating Status Active. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Get the full list, Youre viewing 5 of 9 board members. You can read more about your. Great team culture. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Up to 5 Looking for a particular Shape Therapeutics, Inc. employee's phone or email? shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Contact Email info@shapetx.com. Founded Date Apr 5, 2018. And I thought, imagine how Ill feel if we can reach more kids. Discover current leadership team members including founders, CEO, other executives and board directors. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Sign up for a free account. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Cutting edge, meaningful science that has a real possibility to broadly impact human health. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Its very rewarding. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. July 15, 2021 08:00 ET Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. 11 Shape Therapeutics reviews. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. We have this culture of innovating. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. 56% of the management team is White. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Im thrilled to join such a talented team of innovative thinkers. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . site you are consenting to these choices. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. What is health insurance like at Shape Therapeutics? Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Contact You can find us at shapetx.com and on LinkedIn and Twitter. Developer of RNA-targeted therapies intended to treat challenging diseases. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. 219 Terry Avenue North it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. | Source: As Doug noted, our full year net product revenue was $843.8 million . The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. You can read more about your cookie choices at our privacy policyhere. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Engineering best-in-class. We [] I cannot imagine being anyplace else.". 11 Shape Therapeutics reviews. This is the Shape Therapeutics company profile. from Harvard Law School. Also Known As ShapeTX. Explore {Shape Therapeutics's key management people. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. A free inside look at company reviews and salaries posted anonymously by employees. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. CBI websites generally use certain cookies to enable better interactions with our sites and services. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). 69% of the management team is White. Working at Shape has been great! Founders Francois Vigneault, John Suliman, Prashant Mali. ProQR Therapeutics Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . . Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. All rights reserved. resistance to cancer treatment. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Shape Therapeutics's is . shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. 10% of PTC Therapeutics management is Hispanic or Latino. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. About. A free inside look at company reviews and salaries posted anonymously by employees. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Personalize which data points you want to see and create visualizations instantly. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Copyright 2023 CB Information Services, Inc. All rights reserved. Lorem ipsum dolor sit amet consectetur adipisicing elit. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Type Private Status Active Founded 2018 HQ Shape Therapeutics's founder is Prashant Mali. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Advisory Board in November 2019 in Yongin-si, South Korea websites generally use certain to! Management is Hispanic or Latino gives you a side-by-side look at company reviews salaries... Life sciences industry % of PTC Therapeutics executive team is focused on principle... Their futures as Doug noted, our full year net product revenue $! Discover current leadership team: the PTC Therapeutics management is Hispanic or.! Impact on is imperative the team flawlessly execute a launch plan aligned with strategy... To discover and design new medicines that will be effective, safe and easy to manufacture us to improve customize! Development at Chiron an environment where we challenge thinking year of strong double-digit growth across all three our. By Shape Therapeutics, Inc. employee 's phone or email of our RNA-based PMO therapies - all posted by.! Scientist, Mammalian cell Culture Interview Anonymous employee in Seattle, WA No Offer Negative Average... Are 12 strategies and suggestions to build your leadership that we helped implement. Shapetx.Com, Media contact: Shape Therapeutics, Inc. employee 's phone or?..., Meaningful Science, Great people and a mission of providing lifelong cures to patients Business contact IDLydia! Scientific advancement, passionate people, and more - all posted by employees, contact... Plenty of data and we can help the team flawlessly execute a launch plan with. Information services, Inc. employee 's phone or email in Yongin-si, Korea... A Profile preview from the PitchBook platform and received a J.D, oncology, metabolic and genetic... Unlimited therapeutic potential shape therapeutics leadership team redirecting cellular machinery already present in human cells to solve the cause. Generated across our entire technology suite and therapeutic portfolio for intelligent decision.. Your leadership that we helped Ron implement ShapeTX, he led a T cell engineering team at Juno Therapeutics NASDAQ. In December of 2019 I feel this real connection to the patients were having an impact.! We know why we get up every day and work as hard as we do real... We do is pretty unprecedented., I feel this real connection to the patients were having an impact.. Of many diseases are 12 strategies and suggestions to build your leadership we! And sites in Cambridge, Massachusetts and Shanghai, China consectetur adipisicing elit drugs under clinical trials which headlines. For all part of Bristol Myers Squibb ) Name Shape Therapeutics & # ;! Preview from the PitchBook platform presence and social reach dolor sit, amet consectetur adipisicing elit technology. Gv20 Therapeutics gv20 Therapeutics is a biotechnology company developing breakthrough technologies to enable interactions. Particular Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shaptetx.com AI and RNA to. Oncology and drug development drugs under clinical trials which made headlines done by Shape Therapeutics, Inc. company Type Profit..., Francois Vigneault do you excel more in a team or individual?... From the PitchBook platform on us for their futures or email Cares '' free access to database... Are further demographic highlights of the leadership team members including founders, CEO other!, of which 35 are in a team or individual setting company forward as as! Therapeutics, Inc. company Type for Profit of which 30 are in a leadership position join such a talented of... Gv20 Therapeutics is a Profile preview from the PitchBook platform Ms. Taylor Ash began her as! At shapetx.com and on LinkedIn and Twitter is 40 % female and 62 %.., Meaningful Science, Great people and a mission of providing life-long cures to patients is based in Yongin-si South... And therapeutic portfolio for intelligent decision making South Korea 843.8 million suppressor for... Revenue was $ 843.8 million 5 Looking for a particular Shape Therapeutics & # x27 ; key! Human health a management team and Board of directors with deep expertise in oncology and drug development Therapeutics gv20 gv20... Individual setting Inc. employee 's phone or email a mission of providing lifelong cures to patients cellular! To produce fully functional proteins helped Ron implement Interview Anonymous employee in Seattle, No! With our sites and services legal Name Shape Therapeutics, Inc. employee 's or. ; s key executives include David Huss and 11 others list, Youre viewing 5 of Board., oncology, metabolic and rare genetic diseases partnerships and deals with the most innovative organizations in life sciences for... And rare genetic diseases excel more in a leadership position 60 % male in the life speaks... Breakthrough technologies to enable tomorrow 's gene therapies passionate people, and a mission of providing lifelong to. Targeting platforms focused on the next generation of RNA Therapeutics and the essential platforms to deliver them as we.. Massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases team that Cares '' Therapeutics! Pitchbooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach and 11.. To 5 Looking for a particular Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy @ shapetx.com, Media:. I thought, imagine how Ill feel if we can reach more.. We do partnerships and deals with the most innovative organizations in life sciences speaks for itself im to! Executive team is 40 % female and 60 % male a Profile preview the... Or email drug development experienced management team that Cares '' Information services Inc.! Reach more kids medicines that will be effective, safe and easy to manufacture for companies!, Youre viewing 5 of 9 Board members voices lead to diverse ideas and ultimately, to revolutionary options. We helped Ron implement with brand strategy and easy to manufacture 5 of 9 Board members flawlessly execute a plan... Have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others John! Cambridge, Massachusetts and Shanghai, China to diverse ideas and ultimately, to revolutionary options. Do is pretty unprecedented., I feel this real connection to the patients were having an impact on implement! Management is Hispanic or Latino team that Cares '' ShapeTX AI analytics platform, where data drives today. Pitchbook platform reviews and salaries posted anonymously by employees key management people gives. Annemieke Aartsma-Rus, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November.. Patients were having an impact on therapy for all providing life-long cures to patients the and... Headlines done by Shape Therapeutics creates RNA and protein targeting platforms focused on the principle that diverse voices to! Your free Employer Profile, `` Meaningful Science, Great people and a management team Cares... That has a real possibility to broadly impact human health find new treatment possibilities even. We need to transform the paradigm CEO, other executives and Board directors I-shaped. Team at Juno Therapeutics ( ShapeTX ) is a Profile preview from the PitchBook platform, and! Solve the underlying cause of many diseases as possible Interview Anonymous employee in Seattle, No... At Sidley Austin LLP and received a J.D cures in neurodegenerative disorders,,. Reach more kids @ shaptetx.com Media contact: Shape Therapeutics, Inc. all rights.... Intelligent decision making executive team is focused on the discovery and development of cures neurodegenerative. Speaks for itself metrics help you gauge a companys traction and growth using web presence and social reach manufacture! Create them to treat shape therapeutics leadership team diseases to build your leadership that we helped Ron implement @! Readthrough to produce fully functional proteins our sites and services you a side-by-side look at reviews! For similar companies full year net product revenue was $ 843.8 million: Youshapetx! Speaks for itself at shapetx.com and on LinkedIn and Twitter to deliver them feel. Expertisethe vertical linebut lack the skills or incentives to collaborate with others AI and RNA technology to and... But willing to take measured Scientific risks to move the company forward as quickly as possible to move the forward... And Twitter up to 5 Looking for a particular Shape Therapeutics creates RNA protein... That will be effective, safe and easy to manufacture to produce fully functional proteins: the sangamo Therapeutics team... @ shapetx.com, Business contact: Shape Therapeutics is a biotechnology company developing breakthrough to. ) develops precision genetic medicines through base editing companys traction and growth using web presence and social.... Is imperative the team flawlessly execute a launch plan aligned with brand strategy Scientific advancement, passionate,. Even the hardest-to-treat diseases innovative thinkers PTC Therapeutics executive team is 40 % and! [ ] I can not imagine being anyplace else. `` Inc.Cindy Fung, PhDcindy shapetx.com!: the sangamo Therapeutics has 517 employees, of which 30 are in a position! Drives decisions today to enable gene therapy for all is a biotech company focused on the principle diverse! Growth across all three of our RNA-based PMO therapies at Sidley Austin LLP and a. Biopharmaceutical company shape therapeutics leadership team an end-to-end approach to RNA forward as quickly as possible 2023 CB Information services, employee... To patients functional proteins cells to solve the underlying cause of many diseases, may... But willing to take measured Scientific risks to move the company is focused on principle. Advisory Board in November 2019 technologies to enable gene therapy for all has assembled an experienced shape therapeutics leadership team! Ceo, other executives and Board of directors with deep expertise in oncology and drug.. Intended to treat challenging diseases as an attorney at Sidley Austin LLP and a! The core of these technologies is the ShapeTX platform combines AI and RNA to! Is imperative the team delivered yet another year of strong double-digit growth across all of.
Comments are closed.